CSIMarket
 
Online Disruptive Technologies, Inc.  (ODT)
Other Ticker:  
 
 
Price: $33.5500 $-0.75 -2.187%
Day's High: $34.4 Week Perf: -9.62 %
Day's Low: $ 33.11 30 Day Perf: 24.08 %
Volume (M): 156 52 Wk High: $ 37.99
Volume (M$): $ 5,234 52 Wk Avg: $20.02
Open: $34.25 52 Wk Low: $11.54



 Market Capitalization (Millions $) 4,181
 Shares Outstanding (Millions) 125
 Employees 10
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -89
 Cash Flow (TTM) (Millions $) -0
 Capital Exp. (TTM) (Millions $) 2

Online Disruptive Technologies, Inc.

We were incorporated in the State of Nevada on November 16, 2009 under the name “Online Disruptive Technologies, Inc.” with authorized capital of 500,000,000 shares of common stock with a par value of $0.001 per share and 20,000,000 shares of preferred stock with a par value of $0.001 per share. On March 24, 2010, we entered into a share purchase agreement with Benjamin Cherniak, whereby we acquired all of the issued and outstanding shares of RelationshipScoreboard.com Entertainment, Inc. (“RSE”) in consideration for the issuance of 16,000,000 of our common shares. RSE was incorporated in the State of Nevada on November 16, 2009. There were no related party interests in the acquisition of RSE.

The Savicell™ platform is a blood test designed for the early detection of disease. It is a broad platform with applications for cancer, autoimmune diseases, and infectious diseases. While our focus initially is on early diagnosis of disease, we believe our technology may have additional applications in drug response monitoring for therapies that impact immune response. Immunotherapy, both for treating cancer and autoimmune diseases, is an example where metabolic shift profiles could indicate response to drug treatment.

Initially, Savicell is focused on the multibillion-dollar cancer diagnosis market. Savicell deploys Well-Shield™ technology, a Liquid ImmunoBiopsy™ diagnostic platform. In contrast to existing technologies that evaluate secretions of cancer cells, Well-Shield’s ImmunoBiopsy platform receives data directly from the immune system. Importantly, Well-Shield is different in that it is a functional test measuring the metabolic activation profile of the immune system as an indicator of disease status. As an immune system test, it is inherently suited for early detection.

The technology has now received intellectual property protection with a patent approved in the United States, China, Japan and Europe. Furthermore, the patent process is ongoing in several other countries.

Disease intrusion and cell malformation, including cancer, are first detected by the immune system, which energizes to rid the body of the malignancy. The initial immune response to disease is intricate, deploying different metabolic pathways and subtypes of cells. The Well-ShieldTM technology is designed to detect and interpret these differential metabolic responses.



ODT is expected to report next financial results on August 14, 2019.
 

Jefferies Financial Group Inc.

A $488.80 million tax benefit, helped Jefferies Financial Group Inc to post $0.00 eps in the second quarter

A $488.80 million tax benefit, helped Jefferies Financial Group Inc to post $0.00 eps in the second quarter

Bed Bath & Beyond Inc

Impairment charge hurt Bed Bath & Beyond Inc

Assets impairment charges of $401.27 million, widen comany's losses in the first quarter

Jefferies Group Llc

Jefferies Group Llc announced second quarter operating surplus of $287.077 millions

In the second quarter Jefferies Group Llc reached break-even of $0.00 per share compare to $0.00 a year ago and from $0.00 per share from the previous quarter.

Sales were up by 13.63 % to $1.31 billions from $1.16 billions in the same quarter a year ago and sequentially Sales improved by 24.61 % from $1.05 billions.

Omnova Solutions Inc

Omnova Solutions Inc announced second quarter operating income of $7.2 millions

Omnova Solutions Inc relized deterioration in earnings per share by -36.84 % to $0.12 and Sales decrease by -0.29 % to $205.70 millions in the second quarter, year on year.

Acuity Brands Inc

Profits Surge with Modest Revenue Increase

Acuity Brands Inc achieved double digit earnings growth on moderate Sales increase in the third quarter, where earnings were up by 23.33 % to $2.22 per share, Sales grew modestly by 0.38 % to $947.60 millions from the same quarter a year ago.






   
Major Competitors Stock performance

5 Days Decrease / Increase
     
• View Complete Report
   



             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

KLMK's Profile

Stock Price

KLMK's Financials

Business Description

Fundamentals

Charts & Quotes

KLMK's News

Suppliers

KLMK's Competitors

Customers & Markets

Economic Indicators

KLMK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071